Jt Stratford LLC Biogen Inc. Transaction History

Jt Stratford LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $316,099 - $412,228	-1,117 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $73,038 - $116,948	282 Added 33.77%	1,117 $387,000
Q1 2021 May 12, 2021	BUY	$242.95 - $284.63 $202,863 - $237,666	835 New	835 $234,000
Q1 2020 May 14, 2020	SELL	$268.85 - $341.04 $200,024 - $253,733	-744 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $163,724 - $226,228	744 New	744 $221,000
Q3 2019 Nov 19, 2019	SELL	$217.44 - $243.88 $212,221 - $238,026	-976 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $214,027 - $235,918	976 New	976 $228,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Jt Stratford LLC, based on Form 13F filings with the SEC.

Stay updated on Jt Stratford LLC with notifications on news.